BioVie(BIVI)

年度财报

BioVie(BIVI)08-16 05:15

$BioVie(BIVI)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001520138-25-000268  Act: 34  Size: 5 MB 网页链接查看全文

招股信息更正说明

BioVie(BIVI)10-06 18:05

$BioVie(BIVI)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001520138-25-000294  Act: 33  Size: 595 KB 网页链接查看全文

股东委托书协议

BioVie(BIVI)09-26 05:35

$BioVie(BIVI)$ DEF 14A Other definitive proxy statements Accession Number: 0001520138-25-000287  Act: 34  Size: 728 KB 网页链接查看全文

其他

BioVie(BIVI)10-06 18:05

$BioVie(BIVI)$ POS EX Post-effective amendment adding exhibits to registration statement [Rule 462(d)] Accession Number: 0001520138-25-000293  Act: 33  Size: 246 KB 网页链接查看全文

首次持股声明

BioVie(BIVI)10-28 06:45

$BioVie(BIVI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001520138-25-000326  Size: 8 KB 网页链接查看全文

持股变动声明

BioVie(BIVI)08-14 04:15

$BioVie(BIVI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001520138-25-000251  Size: 7 KB 网页链接查看全文

招股说明书

BioVie(BIVI)10-06 18:05

$BioVie(BIVI)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001520138-25-000292  Act: 33  Size: 791 KB 网页链接查看全文

首次持股声明

BioVie(BIVI)10-28 23:25

$BioVie(BIVI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001520138-25-000327  Size: 8 KB 网页链接查看全文

当期报告

BioVie(BIVI)08-12 04:35

$BioVie(BIVI)$ 8-K Current report, items 1.01, 3.02, 7.01, and 9.01 Accession Number: 0001520138-25-000249  Act: 34  Size: 1 MB 网页链接查看全文

持股变动声明

BioVie(BIVI)2023-01-19 05:27

$BioVie(BIVI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001520138-23-000056  Size: 4 KB 网页链接查看全文

持股变动声明

BioVie(BIVI)2023-01-19 05:27

$BioVie(BIVI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001520138-23-000057  Size: 4 KB 网页链接查看全文

持股变动声明

BioVie(BIVI)2023-01-19 05:27

$BioVie(BIVI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001520138-23-000058  Size: 4 KB 网页链接查看全文

招股说明书

BioVie(BIVI)2022-12-24 06:21

$BioVie(BIVI)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001520138-22-000582  Act: 33  Size: 378 KB 网页链接查看全文

当期报告

BioVie(BIVI)2022-12-24 06:21

$BioVie(BIVI)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001520138-22-000583  Act: 34  Size: 239 KB 网页链接查看全文

招股说明书

BioVie(BIVI)2022-12-15 19:36

$BioVie(BIVI)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001520138-22-000565  Act: 33  Size: 377 KB 网页链接查看全文

当期报告

BioVie(BIVI)2022-12-15 19:36

$BioVie(BIVI)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001520138-22-000566  Act: 34  Size: 238 KB 网页链接查看全文

其他

BioVie(BIVI)2022-12-12 21:06

$BioVie(BIVI)$ RW Registration Withdrawal Request Accession Number: 0001520138-22-000557  Act: NE  Size: 7 KB 网页链接查看全文

牛唐2022-11-29 23:13

$BioVie(BIVI)$ 又一个80%的收益。$拼多多(PDD)$ $蔚来(NIO)$查看全文

三星前高管Cuong Do出任天演药业独立董事与审计委员会成员

美通社2022-11-22 15:58

天演药业宣布任命Cuong Do先生，MBA，为天演董事会的独立董事以及审计委员会成员。Do先生现为临床阶段公司BioVie Inc.的总裁兼CEO。入职BioVie前，Do先生曾担任三星全球战略集团总裁。他还曾担任默沙东公司的首席战略官。(医药健闻)查看全文

首次持股声明

$BioVie(BIVI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001520138-25-000327  Size: 8 KB 网页链接

首次持股声明

$BioVie(BIVI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001520138-25-000326  Size: 8 KB 网页链接

招股说明书

$BioVie(BIVI)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001520138-25-000292  Act: 33  Size: 791 KB 网页链接

其他

$BioVie(BIVI)$ POS EX Post-effective amendment adding exhibits to registration statement [Rule 462(d)] Accession Number: 0001520138-25-000293  Act: 33  Size: 246 KB 网页链接

招股信息更正说明

$BioVie(BIVI)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001520138-25-000294  Act: 33  Size: 595 KB 网页链接

股东委托书协议

$BioVie(BIVI)$ DEF 14A Other definitive proxy statements Accession Number: 0001520138-25-000287  Act: 34  Size: 728 KB 网页链接

年度财报

$BioVie(BIVI)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001520138-25-000268  Act: 34  Size: 5 MB 网页链接

持股变动声明

$BioVie(BIVI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001520138-25-000251  Size: 7 KB 网页链接

当期报告

$BioVie(BIVI)$ 8-K Current report, items 1.01, 3.02, 7.01, and 9.01 Accession Number: 0001520138-25-000249  Act: 34  Size: 1 MB 网页链接

招股说明书

$BioVie(BIVI)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001520138-25-000247  Act: 33  Size: 8 MB 网页链接